Vodafone Certified application status for the MedifyRemote™ application

vodafoneMedify Solutions Limited announced that it has been awarded Vodafone Certified application status for its MedifyRemote™ application. MedifyRemote™ is the first application of its type and allows healthcare professionals mobile access to review and update a patients' medical history records in a single, secure session via a standard Microsoft Windows Mobile PDA/phone device. The application offers no interference with the existing device functions, enabling one device to be utilised for telephone, email, calendar, internet access; as well patient note functions.

In order to achieve Vodafone Certified status, MedifyRemote™ underwent technical evaluation by Vodafone UK. As a result, the application has passed the approval process, meeting the high standards demanded by Vodafone UK's customer base and delivering value to the UK marketplace.

As a Certified application, Medify Solutions Limited now has access to Vodafone UK's technical expertise and will be recommended to appropriate customers by Vodafone UK account managers. MedifyRemote™ will be identified by the "Vodafone Certified Application" brand logo. This will allow Medify Solutions Limited to benefit from Vodafone UK's position as the UK's largest mobile network operator, offering its customers in-depth support and peace of mind when deploying new mobile applications.

Ian O'Reilly, CEO Medify Solutions Limited, said: "Gaining Vodafone Certified status represents a superb endorsement for the MedifyRemote™ application. Our mobile application is successfully leading the way in the UK NHS and the rapid development of the e-Healthcare sector. The recognition of the importance of MedifyRemote™ by a major organisation such as Vodafone UK, underlines the value that this application delivers to clinical users and partners alike. We are very much looking forward to continuing the strong partnership we have formed with Vodafone UK."

Nick Parbutt, Head of Enterprise Product, Vodafone UK said: "For many of our customers, mobile data applications, such as job scheduling or workforce management are a business imperative. Having experienced the business benefits that such applications deliver, these customers are now considering additional solutions to address day-to-day business requirements. Medify Solutions Limited has proven that it can address these needs and we look forward to working with its team to enable our customers to realise the efficiencies that MedifyRemote™ delivers."

MedifyRemote™ joins a number of other Certified application developers in the Vodafone UK applications portfolio which have developed solutions ranging from telematics and sales solutions to tools that replicate the functionality or content from the desktop environment on to the mobile device.

Those interested in further information should email This email address is being protected from spambots. You need JavaScript enabled to view it. or visit www.medifysolutions.com

About the Medify Solutions
The Medify Solutions group of companies are focused on the development, taking to market and delivery of leading edge mobile solutions for the healthcare market. With operations across the EU, Medify are at the forefront of the technology revolution in patient care. For more information, please visit www.medifysolutions.com.

About Vodafone UK
Vodafone UK has 16.3 million customers and is part of the world’s leading international mobile telecommunications Group, offering a wide range of voice and data communications. The company is committed to providing mobile solutions that allow both consumer and business customers to make the most of now. In addition, Vodafone connects customers across the globe with roaming agreements worldwide. It provides 3G roaming in 29 countries and offers great roaming value with Vodafone Passport. For more information, please visit www.vodafone.co.uk.

Most Popular Now

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...